Larvol Delta - Essex-BioTechnology-and-Mitotech-announce-topline-results-from-VISTA1-phase-3-clinical-trial-in-US-FDA-of-a-rstinclass-drug-for-dry-eye-disease

Visomitin (SkQ1 eye drops) - Mitotech, BIO invest

http://www.essexbio.com/uploads/pdf/201907/Phase%203%20Clinical%20Trial%20in%20U.S.%20FDA%20of%20aFirst-In-Class%20Drug%20for%20Dry%20Eye%20Disease-Eng.pdf

Jul 19, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next